CAL
PJP icon

Capital Advisors Ltd’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Capital Advisors Ltd’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,200
Closed -$136K – 403
2016
Q3 		$136K Hold
2,200
– – 0.06% 130
2016
Q2 		$139K Hold
2,200
– – 0.07% 129
2016
Q1 		$132K Hold
2,200
– – 0.07% 128
2015
Q4 		$154K Buy
+2,200
New +$156K 0.08% 111

Other funds holding PJP

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Capital Advisors Ltd's PJP Position: Q4 2016 in Review

Capital Advisors Ltd sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2016, closing a stake of 2,200 shares — an estimated $136K sold.

Capital Advisors Ltd first reported a position in PJP in Q4 2015 and held it in 4 quarters. The position peaked at $154K in Q4 2015. 101 funds tracked by Wall St. Rank hold PJP as of Q4 2016.

  • Capital Advisors Ltd reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2016 after selling out during the quarter.
  • Capital Advisors Ltd sold 2,200 Invesco Pharmaceuticals ETF shares in Q4 2016, an estimated $136K.
  • Capital Advisors Ltd first reported a position in Invesco Pharmaceuticals ETF in Q4 2015 and held it in 4 quarters.
  • Capital Advisors Ltd's Invesco Pharmaceuticals ETF position peaked at $154K in Q4 2015.
  • 101 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2016.

Based on Capital Advisors Ltd's 13F filing for Q4 2016, filed 20 Jan 2017.